Puerarin attenuates amyloid-beta-induced cognitive impairment through suppression of apoptosis in rat hippocampus in vivo

European Journal of Pharmacology

Volumn 649, Issue 1-3, 2010, Pages 195-201

  Li, Jiaming ^a   Wang, Gang ^a   Liu, Jicheng ^a   Zhou, Li ^a   Dong, Miaoxian ^a   Wang, Rui ^a   Li, Xueyan ^a   Li, Xiaoming ^a   Lin, Chunrong ^a   Niu, Yingcai ^a  

^a QIQIHAR MEDICAL UNIVERSITY   (China)

Author keywords

amyloid; Akt; Alzheimer's disease; Apoptosis; Puerarin

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; CASPASE 9; DONEPEZIL; PROTEIN BAD; PROTEIN KINASE B; PUERARIN;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG STRUCTURE; ENZYME ACTIVATION; HIPPOCAMPUS; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; SPATIAL MEMORY;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELLS, CULTURED; COGNITION DISORDERS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; HIPPOCAMPUS; ISOFLAVONES; MALE; MAZE LEARNING; MEMORY DISORDERS; NERVE TISSUE PROTEINS; NEURONS; NEUROPROTECTIVE AGENTS; PHOSPHORYLATION; PHYTOESTROGENS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

EID: 78049296008     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.09.045     Document Type: Article

References (49)

1. Abad M.A., Enguita M., DeGregorio-Rocasolano N., Ferrer I., Trullas R. Neuronal pentraxin 1 contributes to the neuronal damage evoked by amyloid-beta and is overexpressed in dystrophic neurites in Alzheimer's brain. J. Neurosci. 2006, 26:12735-12747.
2. Abdul H.M., Calabrese V., Calvani M., Butterfield D.A. Acetyl-l-carnitine-induced up-regulation of heat shock proteins protects cortical neurons against amyloid-beta peptide 1-42-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease. J. Neurosci. Res. 2006, 84:398-408.
3. Anderson A.J., Stoltzner S., Lai F., Su J., Nixon R.A. Morphological and biochemical assessment of DNA damage and apoptosis in Down syndrome and Alzheimer disease, and effect of postmortem tissue archival on TUNEL. Neurobiol. Aging 2000, 21:511-524.
4. Banu S.K., Lee J., Speights V.O., Starzinski-Powitz A., Arosh J.A. Selective inhibition of prostaglandin E2 receptors EP2 and EP4 induces apoptosis of human endometriotic cells through suppression of ERK1/2, AKT, NFkappaB, and beta-catenin pathways and activation of intrinsic apoptotic mechanisms. Mol. Endocrinol. 2009, 23:1291-1305.
5. Basun H., Bogdanovic N., Ingelsson M., Almkvist O., Näslund J., Axelman K., Bird T.D., Nochlin D., Schellenberg G.D., Wahlund L.O., Lannfelt L. Clinical and neuropathological features of the arctic APP gene mutation causing early-onset Alzheimer disease. Arch. Neurol. 2008, 65:499-505.
6. Carroll J.C., Pike C.J. Selective estrogen receptor modulators differentially regulate Alzheimer-like changes in female 3xTg-AD mice. Endocrinology 2008, 149:2607-2611.
7. Coley N., Andrieu S., Gardette V., Gillette-Guyonnet S., Sanz C., Vellas B., Grand A. Dementia prevention: methodological explanations for inconsistent results. Epidemiol. Rev. 2008, 30:35-66.
8. Csernansky J.G., Wang L., Miller J.P., Galvin J.E., Morris J.C. Neuroanatomical predictors of response to donepezil therapy in patients with dementia. Arch. Neurol. 2005, 62:1718-1722.
9. Dijsselbloem N., Vanden Berghe W., De Naeyer A., Haegeman G. Soy isoflavone phyto-pharmaceuticals in interleukin-6 affections. Multi-purpose nutraceuticals at the crossroad of hormone replacement, anti-cancer and anti-inflammatory therapy. Biochem. Pharmacol. 2004, 68:1171-1185.
10. Du B., Ohmichi M., Takahashi K., Kawagoe J., Ohshima C., Igarashi H., Mori-Abe A., Saitoh M., Ohta T., Ohishi A., Doshida M., Tezuka N., Takahashi T., Kurachi H. Both estrogen and raloxifene protect against beta-amyloid-induced neurotoxicity in estrogen receptor alpha-transfected PC12 cells by activation of telomerase activity via Akt cascade. J. Endocrinol. 2004, 183:605-615.
11. Gagiannis S., Müller M., Uhlemann S., Koch A., Melino G., Krammer P.H., Nawroth P.P., Brune M., Schilling T. Parathyroid hormone-related protein confers chemoresistance by blocking apoptosis signaling via death receptors and mitochondria. Int. J. Cancer 2009, 125:1551-1557.
12. Garcia-Alloza M., Dodwell S.A., Meyer-Luehmann M., Hyman B.T., Bacskai B.J. Plaque-derived oxidative stress mediates distorted neurite trajectories in the Alzheimer mouse model. J. Neuropathol. Exp. Neurol. 2006, 65:1082-1089.
13. Griffin R.J., Moloney A., Kelliher M., Johnston J.A., Ravid R., Dockery P., O'Connor R., O'Neill C. Activation of Akt/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer's disease pathology. J. Neurochem. 2005, 93:105-117.
14. Guerra M.C., Speroni E., Broccoli M., Cangini M., Pasini P., Minghett A., Crespi-Perellino N., Mirasoli M., Cantelli-Forti G., Paolini M. Comparison between Chinese medical herb Pueraria lobata crude extract and its main isoflavone puerarin antioxidant properties and effects on rat liver CYP-catalysed drug metabolism. Life Sci. 2000, 67:2997-3006.
15. Guerrero A.D., Chen M., Wang J. Delineation of the caspase-9 signaling cascade. Apoptosis 2008, 13:177-186.
16. Gutierrez-Zepeda A., Santell R., Wu Z., Brown M., Wu Y., Khan I., Link C.D., Zhao B., Luo Y. Soy isoflavone glycitein protects against beta amyloid-induced toxicity and oxidative stress in transgenic Caenorhabditis elegans. BMC Neurosci. 2005, 6:54.
17. Henderson V.W. Estrogens, episodic memory, and Alzheimer's disease: a critical update. Semin. Reprod. Med. 2009, 27:283-293.
18. Lafay-Chebassier C., Paccalin M., Page G., Barc-Pain S., Perault-Pochat M.C., Gil R., Pradier L., Hugon J. mTOR/p70S6k signalling alteration by Abeta exposure as well as in APP-PS1 transgenic models and in patients with Alzheimer's disease. J. Neurochem. 2005, 94:215-225.
19. Lauzon R.J., Ishizuka K.J., Weissman I.L. Cyclical generation and degeneration of organs in a colonial urochordate involves crosstalk between old and new: a model for development and regeneration. Dev. Biol. 2002, 249:333-348.
20. Lee K.H., Choi E.Y., Kim M.K., Hyun M.S., Eun J.R., Jang B.I., Kim T.N., Kim S.W., Song S.K., Kim J.H., Kim J.R. Hepatocyte growth factor promotes cell survival by phosphorylation of BAD in gastric cancer cells. Oncol. Res. 2008, 17:23-32.
21. Lee H.K., Kumar P., Fu Q., Rosen K.M., Querfurth H.W. The insulin/Akt signaling pathway is targeted by intracellular beta-amyloid. Mol. Biol. Cell 2009, 20:1533-1544.
22. Li W., Pi R., Chan H.H., Fu H., Lee N.T., Tsang H.W., Pu Y., Chang D.C., Li C., Luo J., Xiong K., Li Z., Xue H., Carlier P.R., Pang Y., Tsim K.W., Li M., Han Y. Novel dimeric acetylcholinesterase inhibitor bis7-tacrine, but not donepezil, prevents glutamate-induced neuronal apoptosis by blocking N-methyl-d-aspartate receptors. J. Biol. Chem. 2005, 280:18179-18188.
23. Li Y., Pan W.S., Chen S.L., Xu H.X., Yang D.J., Chan A.S. Pharmacokinetic, tissue distribution, and excretion of puerarin and puerarin-phospholipid complex in rats. Drug Dev. Ind. Pharm. 2006, 32:413-422.
24. Li J., Hu J., Shao B., Zhou W., Cui Y., Dong C., Ezoulin J.M., Zhu X., Ding W., Heymans F., Chen H. Protection of PMS777, a new AChE inhibitor with PAF antagonism, against amyloid-beta-induced neuronal apoptosis and neuroinflammation. Cell. Mol. Neurobiol. 2009, 29:589-595.
25. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
26. Lui V.W., Lam L.C., Chiu H.F. Validation of a memory inventory for the assessment of awareness of memory deficits in Alzheimer's disease in Chinese elderly. Int. J. Geriatr. Psychiatry 2006, 21:917-923.
27. Majd S., Zarifkar A., Rastegar K., Takhshid M.A. Different fibrillar Abeta 1-42 concentrations induce adult hippocampal neurons to reenter various phases of the cell cycle. Brain Res. 2008, 1218:224-229.
28. Miyawaki T., Mashiko T., Ofengeim D., Flannery R.J., Noh K.M., Fujisawa S., Bonanni L., Bennett M.V., Zukin R.S., Jonas E.A. Ischemic preconditioning blocks BAD translocation, Bcl-xL cleavage, and large channel activity in mitochondria of postischemic hippocampal neurons. Proc. Natl. Acad. Sci. USA 2008, 105:4892-4897.
29. Niu Y.C., Pan Z., Li X.M., Zhang C., Liu J.C. The protection action of total isoflavones from Pueraria lobata against MPP+ induced PC12 cellular apoptosis. Chin. Pharmacol. Bull. 2009, 25:112-115.
30. Norman R.J., MacLennan A.H. Current status of hormone therapy and breast cancer. Hum. Reprod. Update 2005, 11:541-413.
31. O'Gorman D.M., McKenna S.L., McGahon A.J., Knox K.A., Cotter T.G. Sensitisation of HL60 human leukaemic cells to cytotoxic drug-induced apoptosis by inhibition of PI3-kinase survival signals. Leukemia 2000, 14:602-611.
32. O'Neill K., Chen S., Diaz Brinton R. Impact of the selective estrogen receptor modulator, tamoxifen, on neuronal outgrowth and survival following toxic insults associated with aging and Alzheimer's disease. Exp. Neurol. 2004, 188:268-278.
33. Oseni T., Patel R., Pyle J., Jordan V.C. Selective estrogen receptor modulators and phytoestrogens. Planta Med. 2008, 74:1656-1665.
34. Park H.J., Kim S.S., Kang S., Rhim H. Intracellular Abeta and C99 aggregates induce mitochondria-dependent cell death in human neuroglioma H4 cells through recruitment of the 20S proteasome subunits. Brain Res. 2009, 1273:1-8.
35. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1982, Academic Press, Sydney. Second edition.
36. Prasain J.K., Jones K., Brissie N., Moore R., Wyss J.M., Barnes S. Identification of puerarin and its metabolites in rats by liquid chromatography-tandem mass spectrometry. J. Agric. Food Chem. 2004, 52:3708-3712.
37. Prasain J.K., Peng N., Moore R., Arabshahi A., Barnes S., Wyss J.M. Tissue distribution of puerarin and its conjugated metabolites in rats assessed by liquid chromatography-tandem mass spectrometry. Phytomedicine 2009, 16:65-71.
38. Quoyer J., Longuet C., Broca C., Linck N., Costes S., Varin E., Bockaert J., Bertrand G., Dalle S. GLP-1 mediates antiapoptotic effect by phosphorylating Bad through a beta-arrestin 1-mediated ERK1/2 activation in pancreatic beta-cells. J. \Biol. Chem. 2010, 285:1989-2002.
39. Simon H.U. Molecules involved in the regulation of eosinophil apoptosis. Chem. Immunol. Allergy 2006, 91:49-58.
40. Su J.C., Lin K.L., Chien C.M., Tseng C.H., Chen Y.L., Chang L.S., Lin S.R. Naphtho[1, 2-b]furan-4, 5-dione inactivates EGFR and PI3K/Akt signaling pathways in human lung adenocarcinoma A549 cells. Life Sci. 2010, 86:207-213.
41. Tu S., Cerione R.A. Cdc42 is a substrate for caspases and influences Fas-induced apoptosis. J. Biol. Chem. 2001, 276:19656-19663.
42. Umschwief G., Shein N.A., Alexandrovich A.G., Trembovler V., Horowitz M., Shohami E. Heat acclimation provides sustained improvement in functional recovery and attenuates apoptosis after traumatic brain injury. J. Cereb. Blood Flow Metab. 2010, 30:616-627.
43. Van Damme P., Martens L., Van Damme J., Hugelier K., Staes A., Vandekerckhove J., Gevaert K. Caspase-specific and nonspecific in vivo protein processing during Fas-induced apoptosis. Nat. Meth. 2005, 2:771-777.
44. Wähälä K., Hase T., Adlercreutz H. Synthesis and labeling of isoflavone phytoestrogens, including daidzein and genistein. Proc. Soc. Exp. Biol. Med. 1995, 208:27-32.
45. Xu X., Zhang S., Zhang L., Yan W., Zheng X. The neuroprotection of puerarin against cerebral ischemia is associated with the prevention of apoptosis in rats. Planta Med. 2005, 71:585-591.
46. Yune T.Y., Park H.G., Lee J.Y., Oh T.H. Estrogen-induced Bcl-2 expression after spinal cord injury is mediated through phosphoinositide-3-kinase/Akt-dependent CREB activation. J. Neurotrauma 2008, 25:1121-1131.
47. Zhang H.Y., Liu Y.H., Wang H.Q., Xu J.H., Hu H.T. Puerarin protects PC12 cells against beta-amyloid-induced cell injury. Cell Biol. 2008, 32:1230-1237.
48. Zhong D., Xiong L., Liu T., Liu X., Liu X., Chen J., Sun S.Y., Khuri F.R., Zong Y., Zhou Q., Zhou W. The glycolytic inhibitor 2-deoxyglucose activates multiple prosurvival pathways through IGF1R. J. Biol. Chem. 2009, 284:23225-23233.
49. Zhu Y., Yang G.Y., Ahlemeyer B., Pang L., Che X.M., Culmsee C., Klumpp S., Krieglstein J. Transforming growth factor-beta 1 increases bad phosphorylation and protects neurons against damage. J. Neurosci. 2002, 22:3898-3909.